Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
367
datasets available to search
ShareScore release 0.9.0
Dataset results
367 results for “Ibrutinib”
Ibrutinib in Combination With Corticosteroids vs Placebo in Combination With Corticosteroids in Participants With New Onset Chronic Graft Versus Host Disease (cGVHD)
ClinicalTrials.gov study NCT02959944. IPD Sharing: YES. Countries: 15. Publications: 1.
A Study of Ibrutinib (PCI-32765) in Chinese Participants With Relapse or Refractory Waldenstrom's Macroglobulinemia (WM)
ClinicalTrials.gov study NCT04042376. IPD Sharing: YES. Countries: 1. Publications: 1.
Smart Start: A Phase II Study of Rituximab, Lenalidomide, and Ibrutinib
ClinicalTrials.gov study NCT02636322. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Inhibition of Anaphylaxis by Ibrutinib
ClinicalTrials.gov study NCT03149315. IPD Sharing: NO. Countries: 1. Publications: 1.
Study of Ibrutinib Combined With Venetoclax in Subjects With Mantle Cell Lymphoma (MCL)
ClinicalTrials.gov study NCT03112174. IPD Sharing: Not stated. Countries: 17. Publications: 2.
Selinexor and Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Aggressive Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT02303392. IPD Sharing: NO. Countries: 1. Publications: 1.
Ibrutinib (PCI-32765) in Waldenstrom's Macroglobulinemia
ClinicalTrials.gov study NCT01614821. IPD Sharing: Not stated. Countries: 1. Publications: 3.
VAY736 in Combination With Ibrutinib in Patients With CLL on Ibrutinib
ClinicalTrials.gov study NCT03400176. IPD Sharing: NO. Countries: 1. Publications: 1.
A Phase I/Ib Safety and Efficacy Study of the PI3K-delta Inhibitor TGR-1202 and Ibrutinib in Patients With CLL or MCL
ClinicalTrials.gov study NCT02268851. IPD Sharing: NO. Countries: 1. Publications: 1.
Ibrutinib and Lenalidomide With Dose Adjusted EPOCH-R in Subjects With Relapsed/Refractory Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT02142049. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Bcl-2 Inhibitor GDC-0199 in Combination With Obinutuzumab and Ibrutinib in Treating Patients With Relapsed, Refractory, or Previously Untreated Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT02427451. IPD Sharing: NO. Countries: 1. Publications: 3.
A Study of the Bruton's Tyrosine Kinase Inhibitor Ibrutinib Given in Combination With Bendamustine and Rituximab in Patients With Newly Diagnosed Mantle Cell Lymphoma
ClinicalTrials.gov study NCT01776840. IPD Sharing: Not stated. Countries: 28. Publications: 1.
A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT01578707. IPD Sharing: Not stated. Countries: 10. Publications: 9.
A Study of the Combination of Ibrutinib Plus Venetoclax Versus Chlorambucil Plus Obinutuzumab for the First-line Treatment of Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lym
ClinicalTrials.gov study NCT03462719. IPD Sharing: Not stated. Countries: 14. Publications: 3.
Study of Ibrutinib (a Bruton's Tyrosine Kinase Inhibitor), Versus Temsirolimus in Patients With Relapsed or Refractory Mantle Cell Lymphoma Who Have Received at Least One Prior Therapy
ClinicalTrials.gov study NCT01646021. IPD Sharing: Not stated. Countries: 21. Publications: 2.
Study of Ibrutinib in Subjects With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT02351037. IPD Sharing: NO. Countries: 1. Publications: 1.
Ublituximab in Combination With Ibrutinib Versus Ibrutinib Alone in Participants With Previously Treated High-Risk Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT02301156. IPD Sharing: NO. Countries: 2. Publications: 1.
A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
ClinicalTrials.gov study NCT01611090. IPD Sharing: Not stated. Countries: 21. Publications: 5.
Study of Ibrutinib and Rituximab in Treatment Naïve Follicular Lymphoma
ClinicalTrials.gov study NCT02947347. IPD Sharing: Not stated. Countries: 19. Publications: 0.
A Multicenter Phase 2 Study of Ibrutinib in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) With 17p Deletion
ClinicalTrials.gov study NCT01744691. IPD Sharing: NO. Countries: 9. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.